Northwestern Medicine researchers have developed a nanoparticle that attacks a cancerous lymphoma cell by mimicking HDL.(high-density lipoprotein) cholesterol, an essential nutrient for the cell.
The nanoparticle tricks the cell by blocking cholesterol from entering the cell. Deprived of an essential nutrient, the cell eventually dies.